Collectively, these findings demonstrate that the NLRP3 inflammasome signaling pathway plays a crucial role in the initiation, progression, and development of AIH, and inhibition of the NLRP3 inflammasome signaling pathway also offers a new and appropriate therapeutic strategy for the treatment of AIH. The gene discussed is NLRP3; the disease is autoimmune hepatitis.